Delivery Order SPE2DB24D3015-SPE2DB26FFWSG
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,313.12 on September 26, 2025, for the supply of Orgovyx 120 mg tablets (30-count unit dose packages). This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 20, 2025, and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,385.52 with firm fixed pricing and is scheduled for completion by August 12, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order, leveraging the company's extensive...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 per unit, with a ceiling value of $1,385.52. This firm fixed-price delivery order, with an ultimate completion date of September 25, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is located in Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $1,385.52 on August 27, 2025, for the supply of Orgovyx 120 mg tablets (30-count units). The contract, which is not set-aside and carries an ultimate completion date of September 18, 2025, is funded through the Defense Logistics Agency's Medical Supply Chain, a component of the Department of Defense. This delivery order represents a single-line pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $2,771.04 with firm fixed pricing and is scheduled for completion by September 9, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued...
- AmerisourceBergen Drug Corp was awarded a competitively-bid delivery order by the Defense Logistics Agency's Medical Supply Chain on May 2, 2025, to supply 30-count bottles of Orgovyx 120 mg tablets. This firm fixed-price contract, with no set-aside designation, carries a ceiling value of $1,385.52 and is scheduled for completion by May 23, 2025. The place of performance is the contractor's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a continuation of the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract is valued at $4,156.56 with a firm fixed-price structure and an ultimate completion date of September 4, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical delivery order, demonstrating the...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,385.52 to supply Orgovyx 120 mg tablets (30-count units) with an ultimate completion date of September 11, 2025. This competitively awarded, non-set-aside contract features firm fixed-price pricing and reflects the DLA's ongoing pharmaceutical procurement needs. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $8,313.12 to AmerisourceBergen Drug Corp for the supply of Orgovyx 120 mg tablets (30-count units) on September 22, 2025, with completion targeted for October 14, 2025. This firm fixed-price, non-competitive delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at approximately $1...
- The Defense Logistics Agency awarded a delivery order valued at $4,156.56 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, represents a non-competitive, non-set-aside award to support federal pharmaceutical procurement needs. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB26FFWSGDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on October 17, 2025, for the supply of Orgovyx 120 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,385.52 and an ultimate completion date of November 7, 2025. The contract was competitively awarded with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's primary distribution hub for federal pharmaceutical procurement. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to military healthcare programs worldwide. As a major pharmaceutical distributor, AmerisourceBergen maintains a substantial federal contract portfolio with DLA and serves critical federal customers including the Defense Health Agency and U.S. Coast Guard, positioning itself as a key vendor in the Department of Defense's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 10/17/25 |